Conference Coverage: EHA 2024 – Focus on NHL and CLL
Lymphoma-specific discussions on the latest research updates, therapeutic advances, and their application in clinical decision-making
June 26, 2024
FACULTY CHAIR
Jason Westin, MD
University of Texas MD Anderson Cancer Center, Houston, TX, USA
Faculty Members
John Allan, MD
Weill Cornell Medicine, New York, NY
Joseph M. Tuscano, MD
University of California Davis Comprehensive Cancer Center, Sacramento, CA
Mazyar Shadman, MD, MPH
Fred Hutchinson Cancer Cancer, Seattle, WA
Philippe Armand, MD, PhD
Dana-Farber Cancer Institute, Boston, MA
Marc S. Hoffmann, MD
University of Kansas Cancer Center, Kansas City, KS
Reem Karmali, MD
Northwestern University Feinberg School of Medicine, Chicago, IL, USA
REPORT SNAPSHOT
- Advances in DLBCL/Aggressive B-Cell Lymphoma
- Advances in Follicular Lymphoma and Mantle Cell Lymphoma
- Updates in T-Cell Lymphoma
- Evolving Therapies in CLL/SLL
